Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing <em>Escherichia coli</em> in Colorectal Cancer

Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing <em>Escherichia coli</em> in Colorectal Cancer

The gut microbiota is crucial for physiological development and immunological homeostasis. Alterations of this microbial community called dysbiosis, have been associated with cancers such colorectal cancers (CRC). The pro-carcinogenic potential of this dysbiotic microbiota has been demonstrated in t...

Full description

Bibliographic Details
Main Authors: Julie Veziant, Romain Villéger, Nicolas Barnich, Mathilde Bonnet
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
intestinal microbiota
CoPEC
colibactin
cancer
<i>E. coli</i>
dysbiosis
Online Access:https://www.mdpi.com/2072-6694/13/9/2215

Similar Items

Similar Items